Work

A Phase II Prospective Multi-institutional Trial of Adjuvant Active Specific Immunotherapy Following Curative Resection of Colorectal Cancer Hepatic Metastases: Cancer and Leukemia Group B Study 89903

Year: 2007

Type: article

Study design: Clinical Trial

Source: Annals of Surgical Oncology

DOI: 10.1245/s10434-007-9654-7

Authors: Mitchell C. Posner, Donna Niedzwiecki, Alan P. Venook, Donna R. Hollis, Hedy L. Kindler, Edward W. Martin, Richard L. Schilsky, Richard M. Goldberg, for the Cancer and Leukemia Group B

Institutions: University of Chicago, Duke Medical Center, University of California, San Francisco, The Ohio State University Wexner Medical Center, University of North Carolina at Chapel Hill, Dana-Farber Cancer Institute

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Ohio State University, National Cancer Institute

Awards: G10814802, G20154349, G220937036, G2296793909, G2647518335, Cancer and Leukemia Group B Statistical Center, Cancer and Leukemia Group B, CANCER AND LEUKEMIA GROUP B, Cancer and Leukemia Group B, Cancer and Leukemia Group B, G739544170, Cancer and Leukemia Group B, Cancer and Leukemia Group B - The Ohio State University, G973482110

OpenAlex ID: W2021609381

FWCI: 1.488

Cites: 21

Cited by: 35

Related to: 10